The lancet. Gastroenterology & hepatology · 1 Oct 2026 · Letter

From viral clearance to cancer prevention: the next phase of hepatitis elimination.

AbdAllah, Abdel-Razek + 1 more

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

WHO global hepatitis report 2026: guiding global action for elimination.
The lancet. Gastroenterology & hepatology · 1 Oct 2026 · Journal Article
Read the brief in JClub
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42508445
Open in JClub
Sustained safety and efficacy of entecavir monotherapy for chronic hepatitis B after liver transplantation: 15-year follow-up.
Gastroenterology · 21 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42767282
Open in JClub
High rates of transition to immune active disease in a cohort of strictly defined immune tolerant patients with chronic hepatitis B: results from the RADICAL consortium.
Gut · 18 Sept 2026 · Journal Article
Over 50% of strictly defined immune tolerant chronic hepatitis B patients transition to immune active disease within five years, especially those with high-normal ALT levels.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42760116
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read